Your browser doesn't support javascript.
loading
Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains.
Wiener, John J M; Gomez, Laurent; Venkatesan, Hariharan; Santillán, Alejandro; Allison, Brett D; Schwarz, Kimberly L; Shinde, Shirin; Tang, Liu; Hack, Michael D; Morrow, Brian J; Motley, S Timothy; Goldschmidt, Raul M; Shaw, Karen Joy; Jones, Todd K; Grice, Cheryl A.
Affiliation
  • Wiener JJ; Johnson & Johnson Pharmaceutical Research & Development L.L.C., 3210 Merryfield Row, San Diego, CA 92121, USA. Jwiener@prdus.jnj.com
Bioorg Med Chem Lett ; 17(10): 2718-22, 2007 May 15.
Article in En | MEDLINE | ID: mdl-17382544
We have previously reported a novel class of tetrahydroindazoles that display potency against a variety of Gram-positive and Gram-negative bacteria, potentially via interaction with type II bacterial topoisomerases. Herein are reported SAR investigations of this new series. Several compounds possessing broad-spectrum potency were prepared. Further, these compounds exhibit activity against multidrug-resistant Gram-positive microorganisms equivalent to that against susceptible strains.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Enzyme Inhibitors / Topoisomerase II Inhibitors / Indazoles / Anti-Bacterial Agents Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2007 Type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Enzyme Inhibitors / Topoisomerase II Inhibitors / Indazoles / Anti-Bacterial Agents Language: En Journal: Bioorg Med Chem Lett Journal subject: BIOQUIMICA / QUIMICA Year: 2007 Type: Article Affiliation country: United States